Jade Biosciences, Inc. (“Jade”), (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for ...

The virtual conference sessions featured speakers who shared their insights on how education, leadership and innovative approaches are shaping the future of healthcare. Sponsored by Elliot Health ...

Incyte (Nasdaq: INCY) announced its participation in the 2025 BofA Securities Health Care Conference. The company’s ...

RANCHO CUCAMONGA, CA / ACCESS Newswire / May 9, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that ...

A webcast of each conference presentation will be available on the “Events & Presentations” page within the Investors section of the Alector website at http ...

Led by Bishop Kevin Kenney, Catholic leaders stopped by the Capitol on Monday to lobby against GOP efforts to revoke health ...

Barry Port, Chief Executive Officer; Chad Keetch, Chief Investment Officer; and Steve Farnsworth, President of Pennant Healthcare LLC, Ensign's northwest subsidiary will present on the company's ...

The Bloom Burton & Co. Healthcare Investor Conference (BBHIC), held in Toronto this week, drew over 1,500 global participants ...

Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced that Progyny's Chief Executive Officer, Pete Anevski, and Chief Financial Officer, Mark ...

Akero Therapeutics will present at the BofA Securities Health Care Conference on May 13, 2025, regarding its metabolic disease treatments. Akero Therapeutics, Inc. announced that its management ...